You are browsing in:
Tag: myxomatous mitral valve disease

Prediction of clinically important acquired cardiac disease without an echocardiogram in large breed dogs using a combination of clinical, radiographic and electrocardiographic variables

S. Wesselowski, S.G. Gordon, N. Meddaugh, A.B. Saunders, J. Häggström, K. Cusack, B.W. Janacek and D.J. Matthews | Journal of Veterinary Cardiology | August 2021
The objectives of this retrospective study were to (1) assess the clinical utility of thoracic radiographs and (2) to explore the potential utility of prediction models incorporating radiographic measurements, physical examination (PE) and electrocardiogram (ECG) to predict clinically important dilated cardiomyopathy (DCM) or myxomatous mitral valve disease (MMVD) in the absence of an echocardiogram in large-breed (LB) dogs…

Vet in the clinic examine with stethoscope a dog breed Yorkshire terrier

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study

B. Besche, T. Blondel, E. Guillot, C. Garelli‐Paar and M.A. Oyama | Journal of Veterinary Internal Medicine | September 2020
The aim of this blinded, randomised, non-inferiority study was to evaluate the efficacy and safety of torasemide, compared to furosemide, in dogs with congestive heart failure (CHF) caused by degenerative mitral valve disease (DMVD)…